GE HEALTHC.TECH.INC. -,01
GE HEALTHC.TECH.INC. -,01/ US36266G1076 /
L0T
08/10/2024 18:42:00
|
Chg.
-0.02
|
Volume |
Bid18:42:00 |
Ask18:42:00 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
81.88EUR
|
-0.02%
|
- Turnover: - |
81.88Bid Size: - |
82.15Ask Size: - |
37.47 bill.EUR |
- |
- |
Business description
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients.
Management board & Supervisory board
CEO |
Peter J. Arduini |
Management board |
James (Jay) Saccaro, Betty Larson, Frank Jimenez, Jan Makela, Kevin O Neill, Thomas Westrick, Elie Chaillot, Catherine Estrampes, Rob Walton, Yihao Zhang, Ken Stacherski, Laila Gurney, Jahid Khandaker, Dr. Taha Kass-Hout, Brian Montgomery, Danielle Halstrom, Carolynne Borders, Abigail Epane-Osuala, Mike Donohoe, Roland Rott |
Supervisory board |
Peter J. Arduini, H. Lawrence Culp, Jr., Dr. Rodney F. Hochman, Lloyd W. Howell, Jr., Dr. Risa Lavizzo-Mourey, Catherine Lesjak, Anne T. Madden, Dr. Tomislav Mihaljevic, William J. Stromberg, Phoebe L. Yang |
Company data
Name: |
GE HealthCare Technologies Inc. |
Address: |
500 West Monroe Street,Chicago, IL 60661 |
Phone: |
+1-617-443-3400 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.gehealthcare.com |
Industry: |
Healthcare |
Sector: |
Medical Products |
Sub sector: |
- |
End of financial year: |
31/12 |
Free Float: |
- |
IPO date: |
04/01/2023 |
Company calendar
CW 42 | 18/10/2024
Record Date
|
CW 42 | 18/10/2024
Ex-Dividend
|
CW 44 | 30/10/2024
Interim Report 3rd Quarter/9 Months
|
CW 46 | 15/11/2024
Dividend Payment
|